Insider Transactions in Q2 2024 at Inmune Bio, Inc. (INMB)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2024
|
Scott Juda Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+6.53%
|
$35,000
$7.27 P/Share
|
|
Apr 19
2024
|
Mark William Lowdell Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,423
+0.95%
|
$115,384
$8.32 P/Share
|
|
Apr 19
2024
|
David J Moss Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,028
+1.4%
|
$144,224
$8.32 P/Share
|
|
Apr 19
2024
|
Raymond Joseph Tesi President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,028
+1.16%
|
$144,224
$8.32 P/Share
|
|
Apr 19
2024
|
Scott Juda Director |
BUY
Grant, award, or other acquisition
|
Direct |
29,603
+30.77%
|
$236,824
$8.32 P/Share
|